FDA Drug Application (203041) for EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number203041
Product Number001
FormTABLET; ORAL
Dosage600MG; 200MG; 300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active IngredientEFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Active IngredientCount
List of drugs with Active Ingredient EFAVIRENZ11
List of drugs with Active Ingredient EMTRICITABINE12
List of drugs with Active Ingredient TENOFOVIR DISOPROXIL FUMARATE15


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD